The Effectiveness of Tele-pulmonary Rehabilitation Program on People With Chronic Obstructive Pulmonary Disease (COPD) After Hospitalization for Acute Exacerbation
2026년 8월 11일 업데이트: Mo Kim Chung, North District Hospital
Introduction: There are great impacts of chronic obstructive pulmonary disease (COPD) over healthcare and economic systems globally. Managing COPD stably in community is still a challenging topic due to its progressive nature, it is valuable to be studied with a view to improving the health status and quality of life in people with COPD and thus relieving the healthcare and economic burdens. Pulmonary rehabilitation (PR) was proven to be cost-effective with clinical benefits in optimizing quality of life, physical conditions and reducing hospital re-admissions rate in people with COPD. Traditionally, PR training was conducted under professional supervision in a face-to-face format. Community-based PR, like tele-rehabilitation, centre-based and homebased rehabilitation are emerging as an effective alternative to traditional PR. Promoting community-based rehabilitation is possibly one of the ways to engage people with chronic diseases in selfmanagement at their doorstep, which will help to tackle the escalating aging population and their heavy burden to the public healthcare system in Hong Kong.
Objectives: The objectives of this study are:
- To evaluate the clinical effectiveness of the newly developed tele-pulmonary rehabilitation program on people with COPD after hospitalized acute exacerbation,
- To explore participants' experience towards the program and develop a deeper understanding about the enablers and barriers faced by participants in joining the - tele-pulmonary rehabilitation program for quality assessment and improvement Methodology: Quasi-experimental design will be adopted in quantitative study, participants will join an eight-session tele-PR program in the intervention group, and participants will join the control group when pending for traditional out-patient based PR program. Purposive sampling will be adopted, participants should be clinically diagnosed COPD, able to participate in scheduled PR program and able to listen, speak, read and understand Chinese. Four domains of outcome measures will be collected, including participant profile, physical health status, health-related quality of life and healthcare resources utilization, for evaluation. Qualitative study with phenomenological approach will be adopted to discover participants' experience in the service. Semistructured, individual face-to-face in-depth interviews will be conducted once participants complete the tele-pulmonary rehabilitation program. Significance: This study will provide solid evidence on the effectiveness of tele-pulmonary rehabilitation program for people with COPD after hospitalized for acute exacerbation.
연구 개요
상태
상태
모병
정황
정황
개입 / 치료
개입 / 치료
연구 유형
연구 유형
중재적
등록 (추정된)
등록
40
단계
단계
- 해당 없음
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 연락처
연구 연락처
- 이름: Kim Chung Mo
- 전화번호: 852 26837822
- 이메일: Dennis.Mo@link.cuhk.edu.hk
연구 장소
-
-
-
Hong Kong, 홍콩
- 모병
- North District Hospital
-
연락하다:
- Kim Chung Mo
- 전화번호: 852 26837822
- 이메일: Dennis.Mo@link.cuhk.edu.hk
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
아니
설명
Inclusion Criteria:
- Clinically diagnosed chronic obstructive pulmonary disease (therefore, with or without confirmation by previous spirometry), no limitation on GOLD stage for participants with previous spirometry; AND
- Aged 18 or above, without limitation on sex, smoking history and medications using; AND
- Able to participate in the scheduled pulmonary rehabilitation program; AND
- Owning private electronic devices and Internet connection at
Exclusion Criteria:
- With unstable medical conditions; OR
- With major musculo-skeletal, neurological, psychiatric or cognitive disorders; OR
- Refusal on clinical study.
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위화되지 않음
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
팔의 수
2
무기와 개입
참가자 그룹 / 팔참가자 그룹 / 팔 |
개입 / 치료개입 / 치료 |
|---|---|
|
간섭 없음: 제어
평소 케어
|
|
|
실험적: Intervention
Tele-pulmonary rehabilitation
|
All exercises content will follow classic pulmonary rehabilitation, but will be conducted in tele-health format
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Six Minute Walk Test (6MWT)
기간: Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
The Six Minute Walk Test (6MWT) uses a standard 30-meter indoor hallway protocol (measurement tool) to evaluate functional exercise capacity.
The unit of measure is the total distance walked in meters.
Scores range from a theoretical minimum of 0 meters to an unlimited maximum based on functional ability; higher values represent a better outcome (greater exercise tolerance).
|
Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
|
Saint George's Respiratory Questionnaire (Hong Kong Chinese version) (SGRQ-HK)
기간: Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
The Saint George's Respiratory Questionnaire (Hong Kong Chinese version) (SGRQ-HK) is a disease-specific questionnaire (measurement tool) used to assess health-related quality of life.
The unit of measure is the SGRQ total score (expressed as a points from 0 to 100).
Scores range from a minimum of 0 to a maximum of 100; higher values mean a worse outcome (greater health impairment and lower quality of life).
|
Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
|
Unplanned hospital re-admission rate
기간: Measure twice at 28-day and 3-month post-hospital discharge, independent to the intervention time-frame
|
The Unplanned Hospital Re-admission Rate uses electronic medical record audit logs to evaluate health resource utilization.
It is a binary variable that 'Yes' or 'No' are the only options.
Unplanned is referring to any unscheduled admissions via Emergency Department, the time frame was within 28 days and within 3 months of the last hospital discharge, the date of the latest hospital discharge is defined as day 0.
|
Measure twice at 28-day and 3-month post-hospital discharge, independent to the intervention time-frame
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Modified Medical Research Council (mMRC) dyspnea scale
기간: Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
The Modified Medical Research Council (mMRC) dyspnea scale is a self-reported categorical rating scale (measurement tool) assessing the severity of breathlessness during daily activities.
The unit of measure is the mMRC grade 0 to 4. Scores range from a minimum grade of 0 (breathless only with strenuous exercise) to a maximum grade of 4 (too breathless to leave the house or breathless when dressing); higher grades mean a worse outcome.
|
Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
|
Dyspnoea-12 (Chinese version) (D-12-C)
기간: Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
The Dyspnoea-12 (Chinese version) (D-12-C) is a 12-item assessing both physical and affective components of breathlessness.
The unit of measure is the D-12-C total score (summed points).
Scores range from a minimum of 0 to a maximum of 36; higher scores mean a worse outcome (more severe dyspnea symptoms).
|
Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
|
Five-Time-Sit-To-Stand test (FTSTS)
기간: Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
The Five-Time Sit-to-Stand test (FTSTS) utilizes a standardized 43-cm chair and stopwatch protocol (measurement tool) to evaluate lower-limb muscle power and functional mobility.
The unit of measure is the time taken to complete 5 repetitions, in seconds.
Scores range from a lower practical bound of 0 seconds (a maximum cutoff of 60 seconds is applied for non-completion); higher times in seconds mean a worse outcome (slower performance and reduced mobility).
|
Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
|
Handgrip strength
기간: Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
Handgrip Strength is measured using a standardized hydraulic hand dynamometer (JAMAR® Model J00105, Lafayette Instrument Company, United States of America) to assess upper-limb isometric muscle strength.
The unit of measure is kilograms of force (kg).
Scores range from a minimum of 0 kg to an upper physiological limit; higher values represent a better outcome (greater muscle strength).
|
Baseline measure within 3 days the participants are discharged from in-patient care; AND post-intervention measure at 8-week after baseline measure
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
연구 시작
2025년 12월 1일
기본 완료 (추정된)
기본 완료
2026년 12월 31일
연구 완료 (추정된)
연구 완료
2027년 3월 31일
연구 등록 날짜
최초 제출
최초 제출
2026년 8월 3일
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
2026년 8월 11일
처음 게시됨 (실제)
처음 게시됨
2026년 8월 13일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
2026년 8월 13일
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
2026년 8월 11일
마지막으로 확인됨
마지막으로 확인됨
2026년 8월 1일
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
기타 연구 ID 번호
- 2025.524
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
아니
미국 FDA 규제 기기 제품 연구
아니
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .